{
    "SPADE_UN_19412": {
        "Sequence Information": {
            "Peptide Name": "Ranalexin (1-7)-Indolicidin (6-13), RN7-IN8\t",
            "Sequence": "FLGGLIKWPWWPWRR",
            "Sequence Length": 15,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P39084",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P39084",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                },
                {
                    "uniprotId": "P33046",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P33046",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae ",
                    "Pubmed ID": "26046345 ",
                    "Reference": "PLoS One. 2015;10:e0128532",
                    "Author": "Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26046345 "
                }
            ],
            "Mass": 1998.38,
            "PI": 12.0,
            "Net Charge": 3,
            "Hydrophobicity": -0.37,
            "Frequent Amino Acids": "WGL",
            "Absent Amino Acids": "ACDEHMNOQSTUVY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 4,
            "Polar Residues": 11,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_19412",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_11682",
                    "Similarity": 1.0,
                    "Sequence": "FLGGLIKPWWPWRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_11683",
                    "Similarity": 1.0,
                    "Sequence": "FLGGLIKKWPWWPWRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_11700",
                    "Similarity": 1.0,
                    "Sequence": "FLGGLIKWWPWRR"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:100% hemolysis=250 µg/ml,Human erythrocytes:0% Hemolysis=15.62 µg/ml,Human lung normal epithelial cells NL20:-=NA,Human lung normal epithelial cells NL20:50% Cell death=125 µg/ml",
            "Target Organism": "Streptococcus pneumoniae(MIC=7.81–15.62µg/ml),Escherichia coli ATCC 25922(MIC=7.81µg/ml),Staphylococcus aureus ATCC 25923(MIC=7.81µg/ml),Staphylococcus aureus(MIC=7.81µg/ml),Pseudomonas aeruginosa ATCC 15442(MIC=31.25µg/ml),Acinetobacter baumannii ATCC 15308(MIC=62.5µg/ml),Enterobacter cloacae(MIC=>250µg/ml),Citrobacter sp.(MIC=>250µg/ml),Klebsiella pneumoniae(MIC=>250µg/ml)"
        }
    }
}